What is Daktari Diagnostics?
Daktari Diagnostics operates at the intersection of advanced medical technology and accessible healthcare solutions. The company is dedicated to developing portable, point-of-care diagnostic platforms designed to provide rapid, laboratory-quality results in resource-limited settings. By focusing on high-impact diagnostic tools, Daktari addresses significant unmet needs in global health, positioning itself as a pivotal player in the shift toward decentralized medical testing. Their market strategy leverages proprietary technology to bridge the gap between complex clinical diagnostics and the immediate needs of healthcare providers in the field.
How much funding has Daktari Diagnostics raised?
Daktari Diagnostics has raised a total of $79.1M across 8 funding rounds:
Series A
$2.8M
Private Equity
$820K
Private Equity
$1.8M
Debt
$1.2M
Series B
$10M
Private Equity
$20M
Series C
$20M
Series D
$22.5M
Series A (2009): $2.8M with participation from Hub Angels Investment Group, Mass Medical Angels, Boston Harbor Angels, Norwich Ventures, and LaunchPad Venture Group
Private Equity (2010): $820K, investors not publicly disclosed
Private Equity (2010): $1.8M, investors not publicly disclosed
Debt (2011): $1.2M, investors not publicly disclosed
Series B (2011): $10M backed by Merck & Co and Norwich Ventures
Private Equity (2013): $20M with participation from Norwich Ventures
Series C (2014): $20M, investors not publicly disclosed
Series D (2015): $22.5M supported by Norwich Ventures and Merck Global Health Innovation Fund
Key Investors in Daktari Diagnostics
Norwich Ventures
Norwich Ventures is a specialized venture capital firm established in 2004, focusing on early-stage medtech investments. The firm seeks to support entrepreneurs developing innovative technologies that address significant unmet medical needs.
Merck Global Health Innovation Fund
The Merck Global Health Innovation Fund is the strategic investment arm of a global healthcare leader, focusing on innovative solutions through prescription medicines, biologic therapies, and vaccines.
Hub Angels Investment Group
Hub Angels Investment Group is a prominent angel investment group based in Boston, specializing in funding young tech and life science companies in the Northeastern United States since 2000.
What's next for Daktari Diagnostics?
With the infusion of capital from its most recent funding round, Daktari Diagnostics is well-positioned to accelerate its commercialization efforts and expand its global footprint. The strategic focus will likely shift toward scaling manufacturing capabilities and deepening penetration into emerging markets where point-of-care diagnostics are most critical. Furthermore, the company is expected to leverage its strong investor network to foster collaborative partnerships that enhance its product pipeline and clinical validation efforts. As the firm matures, the emphasis will remain on maintaining technological superiority while navigating the regulatory and logistical challenges inherent in international healthcare distribution.
See full Daktari Diagnostics company page
